STOCK TITAN

Gilead Sciences (NASDAQ: GILD) insider plans another 3,000-share sale

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Gilead Sciences insider Andrew Dickinson filed a notice to sell 3,000 shares of common stock of GILD through Morgan Stanley Smith Barney LLC, with an aggregate market value of $415,080.00, expected on August 17, 2026. The shares were acquired as Performance Shares on January 31, 2024. Dickinson previously sold 3,000 shares on June 15, 2026 for $376,200.00 and 3,000 shares on July 15, 2026 for $389,776.80.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 3,000 shares Common stock proposed for sale on 08/17/2026
Aggregate market value $415,080.00 Market value of 3,000 shares in proposed 08/17/2026 sale
Sale on 06/15/2026 3,000 shares for $376,200.00 Common stock sold during past three months
Sale on 07/15/2026 3,000 shares for $389,776.80 Common stock sold during past three months
Acquisition date of shares 01/31/2024 Performance Shares from issuer to be sold under Form 144
Planned sale date 08/17/2026 Expected date of Form 144 sale on NASDAQ
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Performance Shares financial
"Common | 01/31/2024 | Performance Shares | Issuer"
Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.
aggregate market value financial
"3000 | 415080.00 | 1239955155 | 08/17/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does Gilead Sciences’ (GILD) latest Form 144 filing disclose?

The filing discloses that Andrew Dickinson plans to sell 3,000 shares of Gilead common stock, with an aggregate market value of $415,080.00, through Morgan Stanley Smith Barney LLC on August 17, 2026.

How many GILD shares are covered by Andrew Dickinson’s new Form 144?

The notice covers a proposed sale of 3,000 shares of Gilead Sciences common stock. These shares were acquired as Performance Shares on January 31, 2024 and are planned to be sold on August 17, 2026 on NASDAQ.

What is the total market value of GILD shares in the proposed Form 144 sale?

The proposed sale involves an aggregate market value of $415,080.00 for 3,000 shares of Gilead common stock. This value reflects the market price used in the Form 144 notice for the planned NASDAQ transaction.

Which broker is handling Andrew Dickinson’s proposed GILD share sale?

The proposed sale of 3,000 Gilead (GILD) shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as disclosed in the Form 144.

What recent GILD stock sales has Andrew Dickinson reported in the past three months?

He reported selling 3,000 shares of Gilead common stock on June 15, 2026 for $376,200.00 and another 3,000 shares on July 15, 2026 for $389,776.80, as listed in the three-month sales section.

When were the GILD shares in the new Form 144 acquired and in what form?

The 3,000 shares covered by the new Form 144 were acquired on January 31, 2024 as Performance Shares from the issuer. This acquisition date and form are disclosed in the "Securities To Be Sold" section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature